Breast Cancer, An Issue of Hematology/Oncology Clinics of North America
- 1st Edition, Volume 37-1 - November 29, 2022
- Latest edition
- Editor: Harold J. Burstein
- Language: English
In this issue of Hematology/Oncology Clinics, guest editor Dr. Harold J. Burstein brings his considerable expertise to Breast Cancer. Top experts provide a comprehensive update on… Read more
Purchase options
In this issue of Hematology/Oncology Clinics, guest editor Dr. Harold J. Burstein brings his considerable expertise to Breast Cancer. Top experts provide a comprehensive update on multidisciplinary management of early- and late-stage breast cancer, including key topics such as global perspectives on the epidemiology and treatment of breast cancer; breast cancer pathology in the era of genomics; optimizing radiation therapy after breast conserving surgery; and more.
-
Contains 16 relevant, practice-oriented topics including disparities in breast cancer outcomes and how to resolve them; genetic testing in breast cancer; the role of ovarian suppression in early stage premenopausal breast cancer; multidisciplinary management of brain metastases from breast cancer; evidence-based guidance for breast cancer survivorship; and more.
-
Provides in-depth clinical reviews on breast cancer, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Oncology
Disparities in Breast Cancer Outcomes and How to Resolve Them
Testing for Inherited Susceptibility to Breast Cancer
Breast Cancer Pathology in the Era of Genomics
Breast Cancer Pathology in the Era of Genomics
Role of Ovarian Suppression in Early Premenopausal Breast Cancer
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
Biology and Treatment of HER2-Low Breast Cancer
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer
Current and Emerging Role of Antibody–Drug Conjugates in HER2-Negative Breast Cancer
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Multidisciplinary Management of Brain Metastasis from Breast Cancer
Systemic Therapy for Hereditary Breast Cancers
Evidence-Based Guidance for Breast Cancer Survivorship
- Edition: 1
- Latest edition
- Volume: 37-1
- Published: November 29, 2022
- Language: English
HB
Harold J. Burstein
Affiliations and expertise
Professor of Medicine, Harvard Medical School, Staff Physician, Brigham And Women's Hospital